Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.41)
# 2,329
Out of 4,778 analysts
195
Total ratings
43.75%
Success rate
-1.62%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: In-Line | $75 → $73 | $71.26 | +2.44% | 11 | Feb 12, 2025 | |
| MTD Mettler-Toledo International | Maintains: Outperform | $1,450 → $1,475 | $1,195.74 | +23.36% | 9 | Feb 10, 2025 | |
| HOLX Hologic | Maintains: In-Line | $76 → $73 | $60.78 | +20.11% | 13 | Feb 6, 2025 | |
| AZTA Azenta | Maintains: In-Line | $50 → $52 | $37.17 | +39.90% | 6 | Feb 6, 2025 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $207 → $202 | $149.91 | +34.75% | 6 | Jan 17, 2025 | |
| NVCR NovoCure | Upgrades: Outperform | $18 → $30 | $18.77 | +59.83% | 11 | Dec 2, 2024 | |
| A Agilent Technologies | Maintains: In-Line | $145 → $142 | $120.50 | +17.84% | 3 | Nov 26, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $80 → $60 | $45.67 | +31.38% | 3 | Nov 6, 2024 | |
| USB U.S. Bancorp | Maintains: In-Line | $51 → $54 | $43.71 | +23.54% | 4 | Oct 30, 2024 | |
| SYK Stryker | Maintains: Outperform | $380 → $384 | $372.96 | +2.96% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $630 → $620 | $514.16 | +20.59% | 10 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $475 → $490 | $519.67 | -5.71% | 11 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $19 → $25 | $15.94 | +56.84% | 7 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $113 → $110 | $110.37 | -0.34% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $368.63 | -3.70% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $44.27 | +26.50% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $125.42 | +27.57% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $88.62 | +17.36% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $102 | $82.44 | +23.73% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $39.41 | +47.17% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $212.48 | +30.84% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $82 → $90 | $103.10 | -12.71% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $228.14 | +27.12% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $125.63 | -1.29% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4.5 → $5 | $3.49 | +43.27% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $32.95 | +36.57% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $16.35 | +65.19% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $87.50 | +100.00% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $107.41 | +16.38% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.82 | +748.79% | 1 | May 31, 2022 |
Edwards Lifesciences
Feb 12, 2025
Maintains: In-Line
Price Target: $75 → $73
Current: $71.26
Upside: +2.44%
Mettler-Toledo International
Feb 10, 2025
Maintains: Outperform
Price Target: $1,450 → $1,475
Current: $1,195.74
Upside: +23.36%
Hologic
Feb 6, 2025
Maintains: In-Line
Price Target: $76 → $73
Current: $60.78
Upside: +20.11%
Azenta
Feb 6, 2025
Maintains: In-Line
Price Target: $50 → $52
Current: $37.17
Upside: +39.90%
J.B. Hunt Transport Services
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $149.91
Upside: +34.75%
NovoCure
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $18.77
Upside: +59.83%
Agilent Technologies
Nov 26, 2024
Maintains: In-Line
Price Target: $145 → $142
Current: $120.50
Upside: +17.84%
Exact Sciences
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $60
Current: $45.67
Upside: +31.38%
U.S. Bancorp
Oct 30, 2024
Maintains: In-Line
Price Target: $51 → $54
Current: $43.71
Upside: +23.54%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $380 → $384
Current: $372.96
Upside: +2.96%
Oct 24, 2024
Maintains: Outperform
Price Target: $630 → $620
Current: $514.16
Upside: +20.59%
Oct 18, 2024
Maintains: In-Line
Price Target: $475 → $490
Current: $519.67
Upside: -5.71%
Oct 15, 2024
Upgrades: Outperform
Price Target: $19 → $25
Current: $15.94
Upside: +56.84%
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $110.37
Upside: -0.34%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $368.63
Upside: -3.70%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $44.27
Upside: +26.50%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $125.42
Upside: +27.57%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $88.62
Upside: +17.36%
Oct 1, 2024
Maintains: Outperform
Price Target: $98 → $102
Current: $82.44
Upside: +23.73%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $39.41
Upside: +47.17%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $212.48
Upside: +30.84%
Oct 1, 2024
Maintains: Outperform
Price Target: $82 → $90
Current: $103.10
Upside: -12.71%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $228.14
Upside: +27.12%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $125.63
Upside: -1.29%
Aug 7, 2024
Maintains: In-Line
Price Target: $4.5 → $5
Current: $3.49
Upside: +43.27%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $32.95
Upside: +36.57%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $16.35
Upside: +65.19%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $87.50
Upside: +100.00%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $107.41
Upside: +16.38%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.82
Upside: +748.79%